ClinVar Miner

Submissions for variant NM_032119.4(ADGRV1):c.12704A>G (p.Tyr4235Cys)

gnomAD frequency: 0.00011  dbSNP: rs200644004
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000606387 SCV000713305 uncertain significance not specified 2017-06-13 criteria provided, single submitter clinical testing The p.Tyr4235Cys variant in GRP98 has been reported in individuals with hearing loss (Miyagawa 2013) and has been identified in 0.03% (35/125796) of European ch romosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitu te.org/; dbSNP rs200644004). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Comp utational prediction tools and conservation analyses suggest that this variant m ay impact the protein, though this information is not predictive enough to deter mine pathogenicity. In summary, the clinical significance of the p.Tyr4235Cys va riant is uncertain.
Fulgent Genetics, Fulgent Genetics RCV000765852 SCV000897248 uncertain significance Usher syndrome type 2C; Febrile seizures, familial, 4 2018-10-31 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001151949 SCV001313137 uncertain significance Usher syndrome type 2C 2017-08-10 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Labcorp Genetics (formerly Invitae), Labcorp RCV001323988 SCV001514927 likely benign not provided 2024-10-19 criteria provided, single submitter clinical testing
GeneDx RCV001323988 SCV002546694 uncertain significance not provided 2022-07-05 criteria provided, single submitter clinical testing Reported in a cohort of patients with hearing loss in published literature (Miyagawa et al., 2013); clinical and molecular information are limited; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 23967202)
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV004817817 SCV005071593 uncertain significance Retinal dystrophy 2022-01-01 criteria provided, single submitter clinical testing
Clinical Genetics, Academic Medical Center RCV001323988 SCV001922028 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001323988 SCV001964390 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.